Generics Maker Says Drug-Safety Program Gets Abused
By Leigh Kamping-Carder ( November 13, 2009, 4:06 PM EST) -- Teva Pharmaceuticals Ltd. has reportedly complained to the Federal Trade Commission that it has been unable to purchase bulk quantities of certain pharmaceuticals because brand-name drug companies are using a federal drug-safety program to unfairly limit competition....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.